Healthcarenews19 Apr, 2024Business
The monoclonal antibody therapeutics market is poised for robust growth, with the market projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024. This represents a compound annual growth rate (CAGR) of 14.5% during the forecast period. The growth of this market is driven by the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, as well as advancements in antibody engineering and production processes.
789betgripe
Events Tech Rental
Customneonslight
Suraj Estate Mahim
Onlinbettingid777
Smmpanel567
Krazio Cloud
Merdekacontractor
London Country Tours
Virat Singh